Company intelligence / Profile preview
Strykagen
Reno, Nevada, United Statesstrykagen.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Strykagen is developing first-in-class small molecule and protein therapeutics targeting rare muscle diseases. Their lead candidate, S‑969, is advancing through IND-enabling studies with NIH SBIR funding. The company’s pipeline includes several preclinical and early clinical programs focused on stabilizing the myomatrix via integrin modulation to halt or reverse disease progression in various forms of muscular dystrophy. They also develop diagnostics for these conditions.
- Therapeutic areas
- Rare DiseasesNeurologyMetabolic Disorders
- Modalities
- Small moleculesProtein therapeutics/biologics
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sarcomatrix Therapeutics Corp. – exclusive research partnership for advancing small molecules promoting muscle regeneration; Sarcomatrix is a clinical-stage biotech company focused on similar indications.
Beyond the preview
Go deeper on Strykagen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Strykagen.